Login
Business
Entertainment
World
Health
Environment
Lifestyle
National
Science
Sports
World
Movies
Web Series
Technology
Cricket
Coronavirus
Auto
Ajab Ghazab
Finance
India
International
Religious
Politics
Home Articles Cary
First US patient enrolled in SELUTION SLR IDE Peripheral Study \
5 min read
\
\

First US patient enrolled in SELUTION SLR IDE Peripheral Study

 24-Aug-2022
Geneva [Switzerland], August 24 (ANI/PRNewswire): The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon. This milestone follows Investigational Device Exemption (IDE) approval in the US in May 2022, with enrollment of the first patient occurring in Germany one week after approval.
24-Aug-2022 Business
\
AQuity accelerates growth and scale with the acquisition of Acusis \
2 min read
\
\

AQuity accelerates growth and scale with the acquisition of Acusis

 16-Mar-2022
New Delhi [India], March 16 (ANI/SRV): AQuity Solutions, a leading provider of virtual solutions for real-time clinical documentation, medical coding, and mid-revenue cycle offerings announced the acquisition of Pittsburgh, PA and India based Acusis.
16-Mar-2022 Business
\
Study: Flexibility in peptides more effective to treat diabetes \
6 min read
\
\

Study: Flexibility in peptides more effective to treat diabetes

 27-Dec-2021
Washington [US], December 27 (ANI): Peptides could be more effective to treat diabetes if they were more flexible and could move back and forth between different shapes, according to a recent study.
27-Dec-2021 Health
\
Flexibility in peptides may be more effective to treat diabetes: Study \
6 min read
\
\

Flexibility in peptides may be more effective to treat diabetes: Study

 23-Dec-2021
Madison [US], December 23 (ANI): According to a new research, peptides could be more effective to treat diabetes if they were more flexible and could move back and forth between different shapes.
23-Dec-2021 Science
\